Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Prepaid Assets (2019 - 2025)

Historic Prepaid Assets for IDEAYA Biosciences (IDYA) over the last 7 years, with Q4 2025 value amounting to $21.4 million.

  • IDEAYA Biosciences' Prepaid Assets rose 5951.92% to $21.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $21.4 million, marking a year-over-year increase of 5951.92%. This contributed to the annual value of $21.4 million for FY2025, which is 5951.92% up from last year.
  • According to the latest figures from Q4 2025, IDEAYA Biosciences' Prepaid Assets is $21.4 million, which was up 5951.92% from $15.8 million recorded in Q3 2025.
  • IDEAYA Biosciences' Prepaid Assets' 5-year high stood at $21.4 million during Q4 2025, with a 5-year trough of $2.8 million in Q1 2022.
  • For the 5-year period, IDEAYA Biosciences' Prepaid Assets averaged around $8.6 million, with its median value being $7.1 million (2023).
  • Its Prepaid Assets has fluctuated over the past 5 years, first tumbled by 2348.41% in 2022, then surged by 16283.58% in 2024.
  • IDEAYA Biosciences' Prepaid Assets (Quarter) stood at $3.1 million in 2021, then surged by 73.36% to $5.4 million in 2022, then soared by 38.53% to $7.5 million in 2023, then surged by 78.59% to $13.4 million in 2024, then surged by 59.52% to $21.4 million in 2025.
  • Its Prepaid Assets stands at $21.4 million for Q4 2025, versus $15.8 million for Q3 2025 and $15.9 million for Q2 2025.